SG
Sarah Gheuens sold $151K of AGIO stock
Sarah Gheuens, Chief Medical Officer of Agios Pharmaceuticals, Inc. (AGIO), sold 4,007 shares of AGIO stock worth $151K, per an SEC Form 4 filed Jul 2, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jul 1, 2026, 1 day before it was made public.
AGIO has moved -14.8% since the trade date, from $37.08 to $31.59 (Nov 13, 2026 close).
- Traded
- Jul 1, 2026
- Disclosed
- Jul 2, 2026
- Filing delay
- 1 day
- Price since
- -14.8%
- Role
- Chief Medical Officer
- Source
- SEC Form 4